Genuine Parts Company vs Revolution Medicines Inc. Common Stock — how do they compare? Genuine Parts Company trades at $126.99 (market cap $17.67B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× Genuine Parts Company's market cap, and Genuine Parts Company pays a 3.32% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| GPC | RVMD | |
|---|---|---|
Market Cap | $17.67B | $40.32B |
Volume | 1,079,458 | 4,855,734 |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $221.15 |
52-Week Low | $92.47 | $47.50 |
Typical Hold Time | 75 Days | 0 Days |
Enterprise Value | $23.76B | $37.02B |
Dividend Yield | 3.32% | — |
Signals from Pluang's Aura AI — not financial advice
GPC trades at $127.02, up 1.28% on the day, with a bullish technical signal and analyst consensus price target of $145.75. Recent quarterly earnings show two beats and one miss, while the company prepares for a planned separation of its automotive and industrial units in Q1 2027. Revenue has grown steadily to $24.3B in 2025, but net income margin is thin at 0.13%.
The outlook is supported by the corporate split catalyst and dividend stability, but risks include compressed profitability and rising debt-to-asset ratios. Wall Street sentiment is mixed, with 43% buy ratings, yet the stock offers value with a P/S of 0.71 and exposure to aging vehicle trends.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →